SCHEMBL8286070

SCHEMBL8286070

C=C(C)CCC(=O)NN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL220310 0.81 KDM4E (0.77) —
SCHEMBL16359624 0.79 — —
Hydrazine SCHEMBL28064827 0.78 KDM4E (0.72) —
SCHEMBL2612192 0.77 — —
SCHEMBL8163507 0.74 KDM4E (0.59) —
Acetone SCHEMBL22554792 0.74 CTSD (0.59) —
Acetone SCHEMBL6392906 0.74 CTSD (0.59) —
SCHEMBL31364147 0.73 KDM4E (0.52) —
SCHEMBL10957159 0.73 KDM4E (0.52) —
SCHEMBL14923078 0.73 FAAH (0.50) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3677579-A1 HETEROCYCLIC GLS1 INHIBITORS Board of Regents, The University of Texas System (US) 2020-07-08 — — EP disclosed
WO-2005080317-A2 THERAPEUTIC AMIDE DERIVATIVES PFIZER JAPAN, INC. (JP) 2005-09-01 — — WO disclosed
Send feedback